LumiraDx develops point-of-care diagnostics solutions on a portable, cloud-connected reader using finger-prick blood samples tested on disposable, microfluidic strips. The company is working to achieve lab-quality performance and health-IT integration at point-of–care settings globally. The foundation invested in the company Read More
Butterfly has created the world’s first handheld whole body ultrasound system to democratize healthcare and provide global access to medical imaging. The device is critical to the foundation’s vision of an ecosystem where hardware, software, data and expertise come together Read More
Theoretically, monoclonal antibodies hold huge potential for safe and highly effective new global health products. Our investment attempted to turn theory into product within this emerging class of drugs.
When a mobile payments platform in Bangladesh achieved product-market-fit, our investment helped it scale in low income, rural areas.
Evolve BioSystems is an infant microbiome company dedicated to developing the next generation of products to establish, restore and maintain a healthy gut microbiome. The foundation is working with Evolve to further develop and apply its lead probiotic, Evivo, to Read More
Stellapps is focused on the development of integrated software and hardware tools that allow dairy processors to manage their supply chains. The primary use case of the Stellapps’ technologies is at milk collection centers where individual SHFs sell their milk. Read More
Zyomyx is a private biotechnology company specializing in HIV CD4 diagnostics.
Visterra is a biotechnology company that uses its proprietary platform to identify unique disease targets and design and engineer effective biological therapeutics.
Vir Biotechnology is a newly-formed company based in San Francisco focused on finding innovative solutions to unmet needs in infectious disease.
Uversity is a mobile app and data solutions company that partners with colleges and universities to improve student enrollment and retention.